Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically Ill patients

Pharmacotherapy

Volumn 25, Issue 10 I, 2005, Pages 1319-1328

  MacLaren, Robert ^a   Sullivan, Patrick W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cost analyses; Critical care; Lorazepam; Midazolam; Pharmacoeconomics; Propofol; Sedation

Indexed keywords

LORAZEPAM; MIDAZOLAM; PROPOFOL;

AGITATION; ARTICLE; COMPUTER PROGRAM; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DRUG COST; EMBASE; EXTUBATION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE UNIT; MEDLINE; MONTE CARLO METHOD; NONHUMAN; NUTRITIONAL DISORDER; PANCREATITIS; SEDATION; VENTILATOR ASSOCIATED PNEUMONIA;

COSTS AND COST ANALYSIS; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; ECONOMICS, PHARMACEUTICAL; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MIDAZOLAM; PROPOFOL;

EID: 26044465789     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.10.1319     Document Type: Article

References (91)

1. Durbin CG Jr. Sedation in the critically ill patient. New Horiz 1994;2(1):64-74.
2. Mazzeo AJ. Sedation for the mechanically ventilated patient. Crit Care Clin 1995;11:9-27.
3. Stoltzfus DP. Advantages and disadvantages of combining sedative agents. Crit Care Clin 1995;11:90-7.
4. Mirski MA, Muffelman B, Ulatowski JA, Hanley DF. Sedation for the critically ill neurologic patient. Crit Care Med 1995;23:2038-53.
5. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics and paralytics in the ICU. Ann Pharmacother 1997;31:148-53.
6. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991;266(20):2870-5.
7. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003;18:139-45.
8. Christensen BV, Thunendborg LP. Use of sedatives, analgesics, and neuromuscular blocking agents in Danish ICUs 1996/97: a national survey. Intensive Care Med 1999;25:186-91.
9. Aitkenhead AR, Pepperman ML, Willatts SM, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989;11:704-9.
10. Boecke A, Lauwers J, Schurink G. A pilot study to compare the use of propofol and midazolam for long-term sedation. J Drug Dev 1989;2(suppl 2):71-2.
11. Boyd O, MacKay CJ, Rushmer F, Bennett ED, Grounds RM. Propofol or midazolam for short-term alterations in sedation. Can J Anesth 1993;40:1142-7.
12. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs. midazolam in short-, medium-, and long-term sedation of critically ill patients. Chest 1993;103:557-64.
13. Carrasco G, Cabre L, Sobrepere G, et al. Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery grafting. Crit Care Med 1998;26:844-51.
14. Chaudhri S, Kenny GNC. Sedation after cardiac by-pass surgery: comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller. Br J Anaesth 1992;68:98-9.
15. Clarke TNS. Propofol compared with midazolam for sedation following prolonged neurosurgery. J Drug Dev 1991;4(suppl 3):108-9.
16. Collard E, Delire V, Mayne A, et al. Propofol-alfentanil versus fentanyl-midazolam in coronary artery surgery. J Cardiothorac Vasc Anesth 1996;10:869-76.
17. Du Gres B, Flamens C. A comparison of propofol and midazolam infusion for postoperative sedation after cardiac surgery. J Cardiothorac Surg 1990;4(suppl 3):101.
18. Farling PA, Johnston JR, Coppel DL. Propofol infusion compared with morphine and midazolam bolus doses for sedation of patients with severe head injuries in the intensive care unit. J Drug Dev 1989;2(suppl 2):97-8.
19. Fruh B. A comparison of propofol and midazolam for long-term sedation of ventilated patients: a cross-over study. J Drug Dev 1989;2(suppl 2):45-7.
20. Grounds RM, Lalor JM, Lumley J, Royston D, Morgan M. Propofol infusion for sedation in the intensive care unit: preliminary report. BMJ 1987;294:397-400.
21. Hall RI, Sandham D, Cardinal P, et al. Propofol vs. midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001;119:1151-9.
22. Anis AH, Wang X, Leon H, Hall R. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002;96:196-201.
23. Hecht U, Lehmkuhl P, Pichlmayr I. Propofol for maintenance of sedation with EEG monitoring. J Drug Dev 1989;2(suppl 2):41.
24. Higgins TL, Yared JP, Estafanous FG, Coyle JP, Ko HK, Goodale DB. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit Care Med 1994;23:1415-23.
25. Marggraf G, Balzereit A, Friedrich I, Schonfelder B, Doetsch N, Reidmeister JC. Post-cardiac surgery sedation [abstr]. Intensive Care Med 1994;20(suppl 2):S140.
26. McMurray TJ, Collier PS, Carson IW, Lyons SM, Elliott P. Propofol sedation after open-heart surgery. Anaesthesia 1990;45:322-6.
27. Roekaerts PMJH, Huygen FJPM, deLange S. Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery. J Cardiothorac Vasc Anesth 1993;7:142-7.
28. Ronan KP, Gallagher TJ, George B, Hambly B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995;23(2):286-93.
29. Searle NR, Cote S, Taillefer J, et al. Propofol or midazolam for sedation and early extubation following cardiac surgery. Can J Anaesth 1997;44:629-35.
30. Snellen F, Lauwers P, Demeyere R, Byttebier G, Van Aken H. The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. Intensive Care Med 1990;16:312-16.
31. Wolfs C, Kimbimbi L, Colin L, Noel F, Neuberg D. A comparison of propofol/fentanyl and midazolam/fentanyl for ICU sedation after abdominal surgery. J Drug Dev 1990;4(suppl 3):69-71.
32. Boyle WA, Shear JM, White PF, Schuller D. Long-term sedative infusion in the intensive care unit: propofol versus midazolam. J Drug Dev 1991;4(suppl 3):43-5.
33. Costa J, Cabre L, Molina R, Carrasco G. Cost of ICU sedation: comparison of empirical and controlled sedation methods. Clin Intensive Care 1994;5(suppl):17-21.
34. Glew RC. Long-term intensive care sedation: a comparison of propofol and midazolam. J Drug Dev 1989;2(suppl 2):55-6.
35. Kress JP, O'Connor MF, Pohlman AS, et al. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am J Resp Crit Care Med 1996;153:1012-18.
36. Ozsezgin S, Gokmen N, Erdem O, Arkan A. Comparison of co-sedation with propofol + midazolam, propofol, and midazolam for sedation of patients undergoing mechanical ventilation in the ICU [abstr]. Br J Anaesth 1999;82(suppl 1):165.
37. Seyde WC, Beyer R, Busse C, et al. Long-term sedation in the intensive care unit: a comparison of propofol and midazolam. J Drug Dev 1989;2(suppl 2):79-80.
38. Beyer R, Seyde WC. Long-term sedation (24h) in the intensive care unit: a comparison of propofol and midazolam. J Drug Dev 1991;4(suppl 4):67-8.
39. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Ricon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997;25:33-40.
40. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernandez M. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001;29:317-22.
41. Berenyi T, Mezofi M. Propofol vs. midazolam for sedation in critically ill patients [abstr]. Br J Anaesth 1995;74:113.
42. Chamorro C, deLatorre FJ, Montera A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicentre trial. Crit Care Med 1996;24:932-9.
43. Degauque C, Dupuis A. A study to compare the use of propofol and midazolam for the sedation of patients with acute respiratory failure. J Drug Dev 1991;4(suppl 3):95-7.
44. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-7.
45. Kress JP, Pohlman AS, Hall JB. Effects of sedation interruption in critically ill, mechanically ventilated patients receiving midazolam or propofol. J Clin Outcomes Manage 2001;8:33-9.
46. Lehmkuhl P, Pichlmar I. Intensive care sedation with propofol or midazolam infusions. J Drug Dev 1991;4(suppl 3):72-3.
47. Millan RJ, Solberg CL, Tschida J, Johnson SV, Hoey LL, Vance-Bryan K. A comparison of propofol and midazolam for sedation in critically ill patients: a retrospective, matched, case-controlled, pilot study [abstr]. Pharmacotherapy 1995;15:370.
48. Pavel C, Nicolau M, Ionica M, Tulbure D, Grintescu I. A comparative study of propofol versus midazolam in long term sedation for multiple trauma patients who need assisted ventilation [abstr]. Br J Anaesth 1999;82(suppl 1):164.
49. Sanchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Perez-Vela JL, et al. Propofol versus midazolam: safety and efficacy for sedating severe trauma patient. Anesth Analg 1998;86:1219-24.
50. Sandiumenge Camps A, Sanchez-Izquierdo Riera JA, Vazquez DT, Sa Borges M, Rodriguez JP, Lopez EA. Midazolam and 2% propofol on long-term sedation of traumatized, critically ill patients: efficacy and safety comparison. Crit Care Med 2000;28:3612-19.
51. Shwed McCollam J, O'Neil MG, Norcoss ED, Byrne TK, Reeves ST. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999;27:2454-8.
52. Weinbroum AA, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997;23:1258-63.
53. Cernaianu AC, DelRossi AJ, Flum DR, et al. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicentre study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med 1996;24:222-8.
54. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of IV lorazepam vs. midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001;95:286-98.
55. Krosner SM, Lin HM, Nagy K, Joseph K, Fildes J, Roberts R. Efficacy and cost: comparison of lorazepam and midazolam for continuous IV sedation in critically injured trauma patients [abstr]. Crit Care Med 1994;22:A54.
56. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994;22(8):1241-7.
57. Swart EL, Strack van Schijndel RJM, van Loenen AC, Thijs LG. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 1999;27:1461-5.
58. Tierney M, Snell CC, Cardinal P, Baxter A. Comparison of duration of mechanical ventilation and cost associated with midazolam and lorazepam infusions in critically ill patients. Can J Hosp Pharm 1996;49:211-15.
59. Manley NM, Fitzpatrick RW, Long T, Jones PW. A cost analysis of alfentanil + propofol vs. morphine + midazolam for the sedation of critically ill patients. Pharmacoeconomics 1997;12:247-55.
60. Popovich MC, Kukreja NR, Woletz J, Qureshi Z, Mascha EJ. Prospective, randomized clinico-economic comparison of three sedation regimens in critically-ill, intubated general ICU patients [abstr]. Anaesthesiology 1999;91:A300.
61. Plainer B, Weinstabl C, Spiss CK, Richling B, Aloy A. Propofol vs. midazolam in combination with sufentanil for continuous sedation in the neurosurgical ICU. J Drug Dev 1989;2(suppl 2):101-3.
62. Jastrzebski J, Gaszynski A, Gaca M, et al. Propofol vs. midazolam in sedation of critically ill patients: the multicenter randomized study [abstr]. Intensive Care Med 1995;21(suppl 1):S170.
63. McNulty SE, Gratch D, Costello D, Heropoulos M, Yun Kim J. The effect of midazolam and lorazepam on postoperative recovery after cardiac surgery. Anesth Analg 1995;81:404-7.
64. Sherry KM, McNamara J, Brown JS, Drummond M. An economic evaluation of propofol/fentanyl compared with midazolam/fentanyl on recovery in the ICU following cardiac surgery. Anaesthesia 1996;51:312-17.
65. Godet G, Gossens S, Prayssac P, et al. Infusion of propofol, sufentanil, or midazolam for sedation after aortic surgery: comparison of oxygen consumption and hemodynamic stability. Anesth Analg 1998;87:272-6.
66. Kox W, Byron C. Effect of sedation with alfentanil, midazolam, and propofol on oxygen transport variables in the critically ill [abstr]. Br J Anaesth 1990;65:278.
67. Wahr JA, Plunkett JJ, Ramsay JG, et al. Cardiovascular responses during sedation after coronary revascularization: incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. Institutions of the McSPI research group. Anesthesiology 1996;84:1350-60.
68. Harris CE, Grounds RM, Murray AM, Lumley J, Royston D, Morgan M. Propofol for long-term sedation in the intensive care unit: a comparison with papaveretum and midazolam. Anaesthesia 1990;45:366-72.
69. Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, Gachoud JP, Suter PM. Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med 1996;22:1186-90.
70. Jacobi J, Fraser GL, Coursin DB, et al. Task force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians: clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
71. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56.
72. Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med 2000;28:854-66.
73. Walder B, Elia N, Henzi I, Romand JR, Tramer MR. A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 2001;92:975-83.
74. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA 2000;283:1451-9.
75. Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetics-pharmacodynamic model. Anesthesiology 2001;95:324-33.
76. Wittbrodt ET. Analysis of pharmacoeconomics of sedation and analgesia. Crit Care Clin 2001;17:1003-13.
77. U.S. Department of Labor, Bureau of Labor Statistics. Consumer price index for medical care. Available from www.bls.gov/cpi/home.htm. Accessed September 25, 2001.
78. Fraser GL, Riker RR, Prato BS, Wilkins ML. The frequency and cost of patient-initiated device removal in the ICU. Pharmacotherapy 2001;21:1-6.
79. Cardinale V, ed. Drug topics red book. Montvale, NJ: Medical Economics Company, 2002.
80. Corsetti JP, Cox C, Schulz TJ, Arvan DA. Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis. Clin Chem 1993;39:2495-9.
81. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
82. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-17.
83. Ben-Menachem T, McCarthy BD, Fogel R, et al. Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med 1996;24:338-45.
84. Medstat Group. DRG 204: disorders of the pancreas except malignancy. In: The DRG guide. Ann Arbor, MI: Medstat Group; 2000.
85. Cohen IL, Bari N, Strosberg MA, et al. Reduction of duration and cost of mechanical ventilation in an intensive care unit by use of a ventilatory management team. Crit Care Med 1991;19:1278-84.
86. Doyle JJ, Casciano JP, Arikian SR, Mauskopf J, Paul JE. Full-cost determination of different levels of care in the intensive care unit: an activity-based costing approach. Pharmacoeconomics 1996;10:395-408.
87. Fryback DG, Stout NK, Rosenberg MA. An elementary introduction to bayesian computing using WinBUGS. Int J Technol Assess Health Care 2001;17(1):98-113.
88. Kress JP, Gehlbach B, Lacy M, Pliskin N, Pohlman AS, Hall JB. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003;168:1457-61.
89. Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 2004;32:1709-14.
90. Yaucher NE, Fish JT, Smith HW, Wells JA. Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy 2003;23:1094-9.
91. Haymen M, Seidl EC, Anderson JA, Harchelroad F. Monitoring lorazepam induced propylene glycol toxicity in a critical care population: a prospective case series [abstr]. Crit Care Med 2003;30:A157.